483
Amgen Manufacturing LtdFDA 483 - Amgen Manufacturing Ltd - May 08, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Amgen Manufacturing Limited (AML) in Juncos, PR, was inspected and cited for significant issues in its Enbrel drug substance manufacturing. Observations included inadequate contamination controls, insufficient performance qualification, ineffective corrective actions for leaks, and non-conformance with the Biologics License Application. These deficiencies led to bacterial contamination and discontinuation of multiple commercial batches.
Open in Dashboard
ID · db055c96-2f65-4c7a-9a05-a08a419d05ad